𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy

✍ Scribed by Keystone, E. ;Burmester, G. R. ;Furie, R. ;Loveless, J. E. ;Emery, P. ;Kremer, J. ;Tak, P. P. ;Broder, M. S. ;Yu, E. ;Cravets, M. ;Magrini, F. ;Jost, F.


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
373 KB
Volume
59
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Anti–tumor necrosis factor α therapy and
✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif